Sign In  |  Register  |  About Walnut Creek Guide  |  Contact Us

Walnut Creek, CA
September 01, 2020 1:43pm
7-Day Forecast | Traffic

  • Search Hotels in Walnut Creek Guide

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Homology Medicines Inc (NQ: FIXX )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Mar 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Homology Medicines Inc

< Previous 1 2 3 4 5 Next >
Bronstein, Gewirtz & Grossman, LLC Notifies Homology Medicines, Inc. (FIXX) Shareholders of Class Action and Encourages Investors to Contact the Firm
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Investor Action Reminder: The Schall Law Firm Encourages Investors in Homology Medicines, Inc. with Losses of $100,000 to Contact the Firm
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal
FIXX Shareholder Class Action: Robbins LLP Reminds Investors of Class Action Against Homology Medicines, Inc. (FIXX)
From Robbins LLP
Via Business Wire
EQUITY NOTICE: ROSEN, A LEADING LAW FIRM, Encourages Homology Medicines, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – FIXX
From Rosen Law Firm
Via Business Wire
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Homology Medicines, Inc. with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
ALERT: Homology Medicines, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - FIXX
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
SHAREHOLDER ALERT: Robbins LLP Informs Shareholders of Class Action Against Homology Medicines, Inc. (FIXX)
From Robbins LLP
Via Business Wire
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Homology Medicines, Inc. with Losses of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
Homology Medicines's Return On Capital Employed Overview
Benzinga Pro data, Homology Medicines (NASDAQ:FIXX) reported Q4 sales of $802.00 thousand. Earnings fell to a loss of $33.58 million, resulting in a 9.72% decrease from last... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Erytech Pharma (NASDAQ:ERYP) stock rose 18.7% to $1.65 during Monday's pre-market session. The market value of their outstanding shares is at $51.1 million.... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers IntriCon (NASDAQ:IIN) shares increased by 37.4% to $23.93 during Monday's regular session. The current volume of 1.0 million shares is 3684.0% of IntriCon'... 
Via Benzinga
Analyst Ratings For Homology Medicines
Analysts have provided the following ratings for Homology Medicines (NASDAQ:FIXX) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish... 
Via Benzinga
67 Biggest Movers From Yesterday
Gainers Mullen Automotive, Inc. (NASDAQ: MULN) climbed 145.6% to close at $1.69 on Monday after the company reported progress on solid-state polymer battery pack... 
Via Benzinga
42 Stocks Moving In Monday's Mid-Day Session
Gainers Mullen Automotive, Inc. (NASDAQ: MULN) jumped 74.4% to $1.20 after the company reported progress on solid-state polymer battery pack development. Renewable Energy Group... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Soleno Therapeutics (NASDAQ:SLNO) shares rose 15.7% to $0.37 during Monday's pre-market session. The market value of their outstanding shares is at $29.5... 
Via Benzinga
10 Biggest Price Target Changes For Monday
Barclays cut the price target on MasTec, Inc. (NYSE: MTZ) from $140 to $120. MasTec shares fell 0.1% to $79.00 in pre-market trading. 
Via Benzinga
Mid-Afternoon Market Update: US Stocks Pare Losses; Meritor Shares Spike Higher
U.S. stocks pared back some losses toward the end of trading on Tuesday. Russian President Vladimir Putin said he would recognize the independence of two Russian-led... 
Via Benzinga
Analyst Ratings For Homology Medicines
Over the past 3 months, 4 analysts have published their opinion on Homology Medicines (NASDAQ:FIXX) stock. These analysts are typically employed by large Wall Street banks and... 
Via Benzinga
73 Biggest Movers From Yesterday
Gainers Imperial Petroleum Inc. (NASDAQ: IMPP) jumped 63.1% to close at $0.80 on Tuesday after declining around 7% on Friday. Indonesia Energy Corporation Limited (NYSE... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Ocugen (NASDAQ:OCGN) stock rose 25.0% to $4.33 during Tuesday's regular session. As of 12:30 EST, Ocugen's stock is trading at a volume of 42.0 million,... 
Via Benzinga
50 Stocks Moving In Tuesday's Mid-Day Session
Gainers Indonesia Energy Corporation Limited (NYSE: INDO) jumped 75.2% to $7.87. Imperial Petroleum Inc. (NASDAQ: IMPP) rose 52.9% to $0.7500 after declining around 7% on Friday... 
Via Benzinga
Mid-Day Market Update: Stocks Extend Losses; Dow Tumbles Over 400 Points
U.S. stocks extended its earlier losses midway through trading on Tuesday, amid rising tensions between Russia and Ukraine. Russian President Vladimir Putin said he would... 
Via Benzinga
Mid-Morning Market Update: U.S. Markets Mixed Amid Russia-Ukraine Woes
U.S. stocks traded mixed this morning, amid rising tensions between Russia and Ukraine. Russian President Vladimir Putin said he would recognize the independence of two Russian-... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Passage Bio (NASDAQ:PASG) shares moved upwards by 15.5% to $3.95 during Tuesday's pre-market session. The company's market cap stands at $213.3 million.... 
Via Benzinga
Homology Medicines Stock Plunges After FDA Clinical Hold On Gene Therapy Trial
The FDA has placed a clinical hold on Homology Medicines Inc's (NASDAQ: FIXX) pheNIX gene therapy trial of HMI-102 from the FDA. An official clinical hold... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
With the long weekend over it's time to start another week of trading with the biggest pre-market stock movers for Tuesday! 
Via InvestorPlace
10 Biggest Price Target Changes For Tuesday
Wells Fargo lowered DraftKings Inc. (NASDAQ: DKNG) price target from $41 to $19. DraftKings shares dropped 5.8% to $16.28 in pre-market trading. 
Via Benzinga
Supernus (SUPN) Moves 5.7% Higher: Will This Strength Last?
Supernus Pharmaceuticals shares soared 5.7% in the last trading session to close at $32.90. The move was backed by solid volume with far more shares changing hands than in a normal session. 
Via Talk Markets
Oxford Biomedica, Homology Medicines Enter Deal To Expand Viral Vector Offerings
London-listed cell and gene therapy Oxford Biomedica Plc (OTC: OXBDF) said it would form a viral vector manufacturing business with Homology Medicines Inc (NASDAQ: FIXX). 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 WalnutCreekGuide.com & California Media Partners, LLC. All rights reserved.